Eileen Leman

Cooley advised Reverence Capital Partners’ portfolio company Transact Campus, an innovative campus technology and payment solutions company, on a definitive agreement signed by Reverence Capital Partners to sell Transact to Roper Technologies for $1.6 billion.

Cooley advised Talkiatry, a top provider of high-quality, in-network psychiatric care, on its $130 million equity and debt financing round.

Cooley advised Community, a short message service (SMS) customer engagement platform that connects businesses, brands, political and public figures, creators, musicians, celebrities and more, on its $25 million Series B financing. Partner Dave Young led the Cooley team.

Cooley advised Gracell Biotechnologies, a global clinical-stage biopharmaceutical company dedicated to developing innovative cell therapies for the treatment of cancer and autoimmune diseases, on its definitive agreement to be acquired by AstraZeneca.

Cooley advised RayzeBio, a clinical-stage radiopharmaceutical therapeutics (RPT) company with an innovation-leading position in actinium-based RPTs and a pipeline of potentially first-in-class and best-in-class drug development programs, on its definitive agreement to be acquired by Bristol Myers Squibb.